DEURUXOLITINIB PHOSPHATE - Food and Drug Administration
- Set ID
- fdf2b747-6482-45b8-968f-e0b7c1f8652b
- Type
- Indexing - product concept
- Effective date
- 2025-03-07
- Version
- 1
- Source
- DailyMed source
Mapped DailyMed Labels#
| Label | Relation | Manufacturer | Effective |
|---|---|---|---|
| These highlights do not include all the information needed to use LEQSELVI safely and effectively. See full prescribing information for LEQSELVI. LEQSELVI ® (deuruxolitinib) tablets, for oral use Initial U.S. Approval: 2024 | Product name | Sun Pharmaceutical Industries, Inc. | 2026-09-28 |
| These highlights do not include all the information needed to use LEQSELVI safely and effectively. See full prescribing information for LEQSELVI. LEQSELVI™ (deuruxolitinib) tablets, for oral use Initial U.S. Approval: 2024 | Product name | Sun Pharmaceutical Industries, Inc. | 2026-07-13 |
| These highlights do not include all the information needed to use LEQSELVI safely and effectively. See full prescribing information for LEQSELVI. LEQSELVI™ (deuruxolitinib) tablets, for oral use Initial U.S. Approval: 2024 | Product name | Sun Pharmaceutical Industries, Inc. | 2025-07-17 |